UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number: 001-38037 SAFE & GREEN HOLDINGS CORP. (Exact name of registrant as specified in its charter) If an emerging growth co ...

Financial Data and Key Metrics Changes - Revenue for Q1 2023 was $5.5 million, down from $8.6 million in Q1 2022, primarily due to the discontinuation of COVID-19 testing facilities, partially offset by increased Construction Services revenue [20] - Operating expenses for Q1 2023 were $2.8 million compared to $2.1 million in Q1 2022, mainly due to increased general and administrative expenses [21][39] - The net loss attributed to common shareholders was approximately $3.2 million or $0.22 per share in Q1 2023, compared to a net loss of $717,000 or $0.06 per share in Q1 2022 [23] - Total gross profit for Q1 2023 was a loss of $69,000 compared to a gross profit of $2.5 million in Q1 2022 [38] Business Line Data and Key Metrics Changes - The Construction Services segment generated $5.5 million in revenue, reflecting a 230% increase compared to the same period last year [20][28] - SG Echo is expected to reach positive cash flow in Q3 2023, marking a significant milestone for the company [11] - The company plans to generate $5 million in annual gross revenue per distinct medical site within Safe & Green Medical [15] Market Data and Key Metrics Changes - The point-of-care diagnostics market is anticipated to expand by more than 40%, amounting to over $51 billion by 2029 [31] - The gross potential value of projects in the planning and approval process stands at $800 million, with an estimated margin of about 15% [16] Company Strategy and Development Direction - The company is focused on four distinct verticals for revenue growth and business expansion [11] - Plans to spin-off SG DevCo into an independent publicly traded company on NASDAQ are anticipated within 90 days, which is expected to unlock considerable value for shareholders [33] - The company is advancing efforts in its Environmental segment, leveraging the Sanitec Microwave Healthcare Waste Disinfecting System for biomedical waste management [34] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to achieve long-term profitability and positive cash flow in the Construction Services segment by Q3 2023 [11][35] - The company is committed to maintaining a lean operating structure while managing expenses to drive substantial cash flow and long-term profitability [36] Other Important Information - The Lago Vista site is expected to be sold for a substantially higher value than its initial purchase price of $3.5 million, providing additional capital [16] - The company has sufficient cash and borrowing capacity to support near-term operations, with a cash balance of $1.5 million as of March 31, 2023 [41] Q&A Session Summary - No specific questions and answers were provided in the content.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number: 001-38037 SAFE & GREEN HOLDINGS CORP. (Exact name of registrant as specified in its charter) | Delaware | 95-4463937 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number: 001-38037 SAFE & GREEN HOLDINGS CORP. (Exact name of registrant as specified in its charter) | Delaware | 95-4463937 | | ...

Financial Data and Key Metrics Changes - The company reported revenue of $4.1 million for Q4 2022, down from $8.5 million in Q4 2021, primarily due to the discontinuation of COVID-19 testing facilities, offset by a 476% increase in construction services revenue [33][43] - Total gross profit for Q4 2022 was $0.3 million, compared to $0.2 million in Q4 2021, reflecting improved gross margin within the construction services segment [34] - The net loss attributable to common shareholders for 2022 was approximately $7.9 million, or negative $0.59 per share, an improvement from a loss of $10.8 million, or negative $1.16 per share in 2021 [39] Business Line Data and Key Metrics Changes - Construction services revenue increased by 476% in Q4 2022 compared to the same period last year, generating $4.2 million [33] - The manufacturing segment, SG Echo, is expected to achieve positive cash flow in 2023, with gross margins anticipated to exceed 15% [15] - SG DevCo plans to construct and own over 3,500 units at various sites, contributing significant cash flow to SG Echo [22] Market Data and Key Metrics Changes - The point-of-care diagnostics market is projected to grow from $36 billion in 2022 to over $51 billion by 2029, indicating substantial growth opportunities for the medical vertical [16] - The company is in the process of building a national sales and service footprint for the Sanitec Microwave Healthcare Waste Disinfection System, targeting an underserved market [29] Company Strategy and Development Direction - The company is focusing on four key verticals, including a medical sector, to drive long-term revenue growth and profitability [11] - A planned spin-out of SG DevCo aims to unlock significant value for shareholders and allow both companies to focus on their core competencies [24][25] - The company is committed to reducing SG&A as a percentage of revenue, expecting to generate positive cash flow within its manufacturing segment [32] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the vast untapped potential within the multi-billion dollar industry, emphasizing the competitive advantage of vertical integration [12] - The outlook for the business is described as brighter than ever, with expectations of scalability and high profitability [32] - Management highlighted the importance of partnerships and unique market positioning in decentralized medical solutions [19] Other Important Information - The company has sufficient cash and borrowing capacity to support near-term operations, with plans to auction the Lago Vista site for additional liquidity [40] - The company signed a 10-year exclusive distribution agreement with Sanitec Industries LLC for biomedical waste disposal solutions [29] Q&A Session Summary Question: What is the expected impact of the spin-out of SG DevCo? - The spin-out is anticipated to provide existing investors with 30% of SG DevCo, unlocking significant value and allowing both companies to focus on their respective growth strategies [24][26] Question: How does the company plan to address the decline in medical revenue? - The company is transitioning back to its core competencies and focusing on establishing a national footprint for medical services, capitalizing on the growing demand for local point-of-care services [16][19]

Financial Data and Key Metrics Changes - For Q3 2022, the company reported revenues of $4.1 million, representing a 612% increase from two years ago [30] - Revenue for the nine months ending September 30, 2022, was $20.3 million on a consolidated basis [30] - The construction segment generated $2.7 million in Q3, a 334% year-over-year increase from Q3 2021 [31] - The company has a total manufacturing pipeline valued at approximately $800 million, with an anticipated gross profit of $120 million based on a 15% margin [40] Business Line Data and Key Metrics Changes - The medical segment generated $1.4 million in Q3 and $11.7 million for the nine months ending September 30, 2022 [32] - The construction segment contributed 65% of revenues for the quarter, while the medical segment contributed 35% [32] - The revenue streams have diversified significantly from a previous concentration of 92% in the medical segment [33] Market Data and Key Metrics Changes - The modular construction market is expected to grow at a CAGR of 8% from 2022 to 2030, with a market size projected to increase from $138 billion in 2021 to $271 billion by 2030 [23] - The healthcare segment accounts for approximately 20% of market revenue within modular construction [25] Company Strategy and Development Direction - The company is focused on expanding its manufacturing footprint and capabilities to support a growing pipeline of projects [19][21] - The strategy includes building projects largely out of its own factories to maximize benefits and minimize transportation costs [41] - The company aims to reach a pipeline of 5,000 units on a year-over-year basis as it develops various phases of each project [43] Management's Comments on Operating Environment and Future Outlook - The company is optimistic about its long-term business plans, including entering the medical waste recycling industry [27] - Management expressed confidence in the company's ability to execute on contracts and expand revenue streams in 2023 [36][38] - The company is currently debt-free and has a strong cash position, allowing for continued share buyback programs [34][35] Other Important Information - The total appraised value of the company's real estate portfolio is $56.4 million, significantly higher than the conversion purchase price of $8 million [17] - The company has completed renovations on its second facility and is on track to begin module production in Q1 2023 [20] Q&A Session Summary Question: Concerns about revenue growth despite press releases - Management indicated that the $800 million backlog will be built out and earned over three to five years, and future revenue growth will depend on project execution [49][51] Question: Margins on SG Echo builds and SG Dev Corp - Management stated that SG Echo projects typically operate on an 18% to 20% margin, while SG Dev Corp projects will be delivered at a 15% margin for transparency [58]

SG Blocks, Inc. (NASDAQ:SGBX) Q2 2022 Results Conference Call August 15, 2022 4:30 PM ET Company Participants Paul Galvin - Chairman and Chief Executive Officer Mark Moran - Chief Executive Officer, Equity Animal Mark Moran Greetings and welcome to SG Blocks Second Quarter Earnings Call. I'm Mark Moran CEO of Equity Animal. Will be host of our call today. I'm here with Paul Galvin, Chairman and CEO of the company. If you weren't doing so already, it is easy to participate in the call on Twitter spaces. On T ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number: 001-38037 SG BLOCKS, INC. (Exact name of registrant as specified in its charter) | Delaware | 95-4463937 | | --- | -- ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number: 001-38037 SG BLOCKS, INC. (Exact name of registrant as specified in its charter) | Delaware | 95-4463937 | | --- | - ...

SG Blocks, Inc. (NASDAQ:SGBX) Q4 2021 Earnings Conference Call April 18, 2022 4:30 PM ET Company Participants Stephanie Prince - PCG Advisory Paul Galvin - Chairman and Chief Executive Officer Gerald Sheeran - Acting Chief Financial Officer Conference Call Participants Operator Good day and welcome to SG Blocks Fourth Quarter and Year-End 2021 Earnings Conference Call and Webcast. Today’s conference call is being recorded. At this time, I would like to turn the conference over to Stephanie Prince of PCG Adv ...